2-214792440-C-A

Variant summary

Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM1PP3_Strong

The NM_000465.4(BARD1):​c.221G>T​(p.Cys74Phe) variant causes a missense change. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C74Y) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000021 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000099 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

BARD1
NM_000465.4 missense

Scores

13
4
1

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:6

Conservation

PhyloP100: 5.10

Publications

6 publications found
Variant links:
Genes affected
BARD1 (HGNC:952): (BRCA1 associated RING domain 1) This gene encodes a protein which interacts with the N-terminal region of BRCA1. In addition to its ability to bind BRCA1 in vivo and in vitro, it shares homology with the 2 most conserved regions of BRCA1: the N-terminal RING motif and the C-terminal BRCT domain. The RING motif is a cysteine-rich sequence found in a variety of proteins that regulate cell growth, including the products of tumor suppressor genes and dominant protooncogenes. This protein also contains 3 tandem ankyrin repeats. The BARD1/BRCA1 interaction is disrupted by tumorigenic amino acid substitutions in BRCA1, implying that the formation of a stable complex between these proteins may be an essential aspect of BRCA1 tumor suppression. This protein may be the target of oncogenic mutations in breast or ovarian cancer. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2013]
BARD1 Gene-Disease associations (from GenCC):
  • BARD1-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast cancer
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • hereditary breast carcinoma
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 6 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 8 benign, 32 uncertain in NM_000465.4
PP3
MetaRNN computational evidence supports a deleterious effect, 0.974

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000465.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BARD1
NM_000465.4
MANE Select
c.221G>Tp.Cys74Phe
missense
Exon 3 of 11NP_000456.2Q99728-1
BARD1
NM_001282543.2
c.164G>Tp.Cys55Phe
missense
Exon 2 of 10NP_001269472.1Q99728-2
BARD1
NM_001282549.2
c.221G>Tp.Cys74Phe
missense
Exon 3 of 5NP_001269478.1A0A087WZ19

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BARD1
ENST00000260947.9
TSL:1 MANE Select
c.221G>Tp.Cys74Phe
missense
Exon 3 of 11ENSP00000260947.4Q99728-1
BARD1
ENST00000617164.5
TSL:1
c.164G>Tp.Cys55Phe
missense
Exon 2 of 10ENSP00000480470.1Q99728-2
BARD1
ENST00000613706.5
TSL:1
c.221G>Tp.Cys74Phe
missense
Exon 3 of 11ENSP00000484976.2A0A087X2H0

Frequencies

GnomAD3 genomes
AF:
0.0000214
AC:
3
AN:
139932
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000239
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000527
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000993
AC:
132
AN:
1329472
Hom.:
0
Cov.:
32
AF XY:
0.0000978
AC XY:
65
AN XY:
664756
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000172
AC:
5
AN:
29044
American (AMR)
AF:
0.00
AC:
0
AN:
38220
Ashkenazi Jewish (ASJ)
AF:
0.000129
AC:
3
AN:
23338
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36150
South Asian (SAS)
AF:
0.0000384
AC:
3
AN:
78160
European-Finnish (FIN)
AF:
0.0000832
AC:
4
AN:
48062
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5276
European-Non Finnish (NFE)
AF:
0.000112
AC:
114
AN:
1016992
Other (OTH)
AF:
0.0000553
AC:
3
AN:
54230
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.234
Heterozygous variant carriers
0
25
50
75
100
125
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000214
AC:
3
AN:
140034
Hom.:
0
Cov.:
30
AF XY:
0.0000445
AC XY:
3
AN XY:
67416
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
37538
American (AMR)
AF:
0.00
AC:
0
AN:
13452
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3380
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4548
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4100
European-Finnish (FIN)
AF:
0.000239
AC:
2
AN:
8374
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
282
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
65558
Other (OTH)
AF:
0.000521
AC:
1
AN:
1918
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.275
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
Familial cancer of breast (2)
-
2
-
Hereditary cancer-predisposing syndrome (2)
-
2
-
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.94
BayesDel_addAF
Pathogenic
0.56
D
BayesDel_noAF
Pathogenic
0.56
CADD
Pathogenic
27
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.61
D
Eigen
Pathogenic
0.95
Eigen_PC
Pathogenic
0.85
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.76
T
M_CAP
Pathogenic
0.68
D
MetaRNN
Pathogenic
0.97
D
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Pathogenic
4.1
H
PhyloP100
5.1
PrimateAI
Uncertain
0.63
T
PROVEAN
Pathogenic
-7.2
D
REVEL
Pathogenic
0.93
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.88
MutPred
0.80
Gain of glycosylation at S76 (P = 0.0879)
MVP
1.0
MPC
0.53
ClinPred
1.0
D
GERP RS
5.4
Varity_R
0.99
gMVP
0.91
Mutation Taster
=46/54
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs876658459; hg19: chr2-215657164; COSMIC: COSV107297670; COSMIC: COSV107297670; API